Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

12.9K
We explored a tubal cytologic method by sampling the fallopian tube directly post-surgical excision as a tool of ovarian cancer early detection. Here, we present a protocol to collect fallopian tube cells from freshly received surgical...
12.9K
Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells08:33

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells

20.3K
Three dimensional culture of mammary epithelial cells on a reconstituted basement membrane is a useful method to recapitulate the in vivo architecture of the benign breast, and to differentiate the malignant phenotype from the benign breast phenotype. Importantly, this system can be applied to study invasive carcinomas in other...
20.3K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

7.5K
Transgenic lck:eGFP zebrafish express GFP highly in T lymphocytes, and have been used to study T cell development and acute lymphoblastic leukemia. This line can be used to study B cells, which express lck at lower levels. This protocol describes purification of malignant and non-malignant B cells from lck:eGFP...
7.5K
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy05:24

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

761
This study introduces multifractal spectrum analysis for assessing pulmonary nodule malignancy. Using CT-DICOM data, the method calculates fractal dimensions across multiple voxel scales, revealing significant differences between early-stage and late-stage pulmonary...
761
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

1.5K
This protocol describes the in vivo reprogramming of mouse cancer cells into type 1 dendritic-like cells within the tumor microenvironment through enforced expression of the transcription factors PU.1, IRF8, and...
1.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

21.0K
The fundamentals of radiation planning and delivery for proton therapy using prostate cancer as a model are presented. The application of these principles to other selected disease sites highlights how proton radiotherapy may enhance clinical outcomes for cancer...
21.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world assessment of low-density lipoprotein cholesterol goal, disease burden and financial burden among patients with atherosclerotic cardiovascular disease in Singapore-A single-centre retrospective cohort study.

Frontiers in cardiovascular medicine·2026
Same author

Autonomous positive-feedback DNA walker cascade for ultrasensitive detection of DNA repair glycosylases.

Biosensors & bioelectronics·2026
Same author

Non-Destructive Early Sex Identification of Embryonated Quail Eggs Using Raman Spectroscopy.

Animals : an open access journal from MDPI·2026
Same author

Research on the mechanism of Duhuo in treating intervertebral disc degeneration based on bioinformatics and network pharmacology.

Medicine·2026
Same author

Flagellar Motor Dynamics of <i>E. coli</i> Persisters under High-Load Reveal Impaired Performance and a Divergent Nonequilibrium State.

The journal of physical chemistry. B·2026
Same author

Umbilical cord blood natural killer cells improve anti-GD2 antibody efficacy in neuroblastoma: from mouse to human.

Oncoimmunology·2026

Related Experiment Video

Updated: Jan 20, 2026

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.9K

Cancer cell reprogramming: a promising therapy converting malignancy to benignity.

Lanqi Gong1,2, Qian Yan1,2, Yu Zhang1,2

  • 1Department of Clinical Oncology, The University of Hong Kong, Hong Kong, 999077, P.R. China.

Cancer Communications (London, England)
|August 30, 2019
PubMed
Summary

Cancer cell reprogramming offers therapeutic potential by restoring normal cell functions. Overcoming challenges in mechanisms, efficiency, and safety is key for clinical translation of this promising cancer therapy.

Keywords:
BenignCancer cell reprogrammingCancer stem cellExosomeInduced pluripotent stem cellMalignancyMicroRNAPluripotencySmall moleculeTranscription factor

More Related Videos

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
08:33

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells

Published on: April 25, 2014

20.3K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.5K

Related Experiment Videos

Last Updated: Jan 20, 2026

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.9K
Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
08:33

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells

Published on: April 25, 2014

20.3K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.5K

Area of Science:

  • Cell biology
  • Biotechnology
  • Cancer research

Background:

  • Significant advancements in cell reprogramming have been achieved over the last decade.
  • Reprogramming techniques include transcription factors, small molecules, microRNAs, and exosomes.
  • These methods facilitate epigenetic changes and cell fate determination.

Purpose of the Study:

  • To review recent applications of cancer cell reprogramming.
  • To focus on the clinical significance and limitations of various reprogramming strategies.
  • To summarize the roles of key factors (transcription factors, small molecules, microRNAs, exosomes) in reprogramming.

Main Methods:

  • Literature review of recent studies on cancer cell reprogramming.
  • Analysis of different reprogramming approaches and their mechanisms.
  • Evaluation of clinical potential and challenges.

Main Results:

  • Cancer cell reprogramming shows promise for retrieving normal cell functions.
  • Key reprogramming methods involve transcription factors, small molecules, microRNAs, and exosomes.
  • Progress has been made in understanding mechanisms and improving efficiency.

Conclusions:

  • Cancer cell reprogramming is a versatile approach with therapeutic potential against malignancies.
  • Major obstacles for clinical translation include mechanism characterization, efficiency, safety, and delivery.
  • Further research is needed to overcome these challenges for future cancer therapies.